Over the weekend the Miami New Times has released reports showing that several MLB players, including NY Yankees’ Alex Rodriguez, have been taking HGH, a substance banned in baseball.
All this coming out from an investigation lead by the MLB and the Drug Enforcement Administration into a clinic in Miami run by Anthony Bosch, an adviser and consultant to many baseball players.
The Miami New Times has been given patient records form an anonymous source suggesting that A-Rod, along with other players, has been given HGH by Bosch on a regular basis. This going against A-Rod’s claim that he hasn’t used PEDs since 2003.
“Yet there was his name, over and over again, logged as either ‘Alex Rodriguez,’ ‘Alex Rod,’ or his nickname at the clinic, ‘Cacique,’ a pre-Columbian Caribbean chief. Rodriguez’s name appears 16 times throughout the records New Times reviewed.
Take, for instance, one patient list from Bosch’s 2009 personal notebook. It charts more than 50 clients and notes whether they received their drugs by delivery or in the office, how much they paid, and what they were taking.
There, at number seven on the list, is Alex Rodriguez. He paid $3,500, Bosch notes. Below that, he writes, ‘1.5/1.5 HGH (sports perf.) creams test., glut., MIC, supplement, sports perf. Diet.’ HGH, of course, is banned in baseball, as are testosterone creams.
The mentions of Rodriguez begin in 2009 and continue all the way through last season. Take a page in another notebook, which is labeled ‘2012’ and looks to have been written last spring.
Under the heading ‘A-Rod/Cacique,’ Bosch writes, ‘He is paid through April 30th. He will owe May 1 $4,000… I need to see him between April 13-19, deliver troches, pink cream, and… May meds. Has three weeks of Sub-Q (as of April).’”
Sub-Q is described as a mixture of HGH, IGF-1, and several other drugs. Others that were mentioned in the records include Yasmani Grandal, Bartolo Colon, Melky Cabrera, and Nelson Cruz. Gio Gonxalaez is likewise mentioned, but the records aren’t definitive.
Paul Hudson | Elite.